Gilead Sciences | سهم



Stock تغيير تاريخ
AbbVie USD 4.18B 269M 2024-12
Agios Pharmaceuticals USD 27.62M 1.19M 2024-12
ALKERMES USD 182.89M 8.2M 2024-12
Alnylam Pharmaceuticals USD 78.51M 2.52M 2024-12
Amgen USD 7B 364M 2024-12
Biogen USD 2.46B 8.7M 2024-12
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Bristol-Myers Squibb USD 2.56B 775M 2024-12
Eli Lilly USD 7.59B 129.4M 2024-12
Gilead Sciences USD 3.59B 154M 2024-12
GlaxoSmithKline GBP 5.67B 249M 2024-12
Glaxosmithkline 5.92B 216M 2024-09
Incyte USD 58.87M 11.57M 2024-12
J&J USD 12.44B 159M 2024-12
Merck USD 6.11B 135M 2024-12
Moderna USD 117M 295M 2024-12
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Novartis USD 5.72B 216M 2024-12
Pfizer USD 10.85B 870M 2024-12
PTC Therapeutics USD 35.67M 3.84M 2024-09
Regeneron Pharmaceuticals USD 3.09B 69.3M 2024-12
Sanofi EUR 10.61B 943M 2024-06
Sarepta Therapeutics USD 749.96M 184.04M 2024-12
United Therapeutics USD 157.9M 11.2M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



Gilead Sciences سهم - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.